The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)
| Status: | Recruiting |
|---|---|
| Conditions: | Skin and Soft Tissue Infections, Dermatology, Dermatology, Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 18 - 100 |
| Updated: | 1/9/2019 |
| Start Date: | July 2014 |
| End Date: | July 2040 |
| Contact: | Viictoria K Shanmugam, MD |
| Email: | vshanmugam@mfa.gwu.edu |
| Phone: | 202-741-2488 |
The Scleroderma bioreposiTOry and Pathogenesis Study (STOP Scleroderma) will help researchers
use clinical data and human biospecimens to investigate why scleroderma patients develop
certain complications from their disease. Patients with confirmed scleroderma, raynauds or
positive autoantibodies are invited to participate. This research may help us understand how
to prevent and treat scleroderma and other diseases.
use clinical data and human biospecimens to investigate why scleroderma patients develop
certain complications from their disease. Patients with confirmed scleroderma, raynauds or
positive autoantibodies are invited to participate. This research may help us understand how
to prevent and treat scleroderma and other diseases.
Inclusion Criteria:
- Age >18 years
- Able to give informed consent.
- Diagnosed with scleroderma or with positive autoantibodies
Exclusion Criteria:
- < 18 years old
We found this trial at
1
site
Click here to add this to my saved trials
